查询词典 vasopressor

Background Vasopressin is an alternative to epinephrine for vasopressor therapy during cardiopulmonary resuscitation, but clinical experience with this treatment has been limited.

尚难确定。有研究发现，与室颤及无脉性电活动患者的研究结果不同，心脏停搏患者接受加压素治疗后入院存活率比接受肾上腺素治疗者高4JD％。

However, these feedings are discontinued after the development of escalating vasopressor requirements, worsening abdominal distention, and increased gastric residual volume, along with an episode of emesis.

然而，由于患者对血管升压药的需求不断升级，腹胀越来越重和胃残留容积增加，并且出现了一次呕吐，管饲被停止。

In addition, constant infusions of a vasopressor agent phenylephrine (2 mg kg-1 min-1) after the onset of heatstroke failed to maintain appropriate levels of mean arterial pressure and resulted in no protection against heatstroke. Thus, it appears that the observed benefit of the 10% albumin is secondary to hemodilution and/or maintenance of mean arterial pressure.

另外，在热中风发作后持续滴注血管增压剂 phenylephrine (2 mg Kg-1 min-1)，并没有办法维持适当平均动脉压，而无法保护大鼠热中风伤害，所以，这种结果显示注射 10%白蛋白所获得的效果是因为血液稀释及／或维持平均动脉血压。

CLINICAL PRESENTATION: Over a 2-year period, the medical records of 16 patients admitted to the adult neurosurgery service for aneurysmal subarachnoid hemorrhage who were nonresponsive to vasopressor therapy and received cosyntropin for the evaluation of adrenal insufficiency within 14 days of their event were reviewed.

临床表现：在2年的时间内，在成人神经外科，我们收治了16名动脉瘤性蛛网膜下腔出血的病人。这些患者对血管加压治疗不敏感，并在出血后14天内接受了用促肾上腺激素来评估肾上腺功能不全。

Assessment of the prognostic value of initial thrombocytopenia was based on either 30-day death or 30-day composite event (death, cardiopulmonary resuscitation, mechanical ventilation, thrombolytic treatment and vasopressor therapy).

评估病患短期预后的指标为30天内的死亡率以及30天内的综合并发症发生率（包括：死亡、实行心肺复苏术、气道插管、病程治疗中需给予血栓溶解剂者、需给予升压剂者）。

In patients with clinical evidence of hypotension associated with hypoperfusion and obvious evidence of elevated cardiac filling pressures (e.g., elevated jugular venous pressure; elevated pulmonary artery wedge pressure), intravenous inotropic or vasopressor drugs should be administered to maintain systemic perfusion and preserve end-organ performance while more definitive therapy is considered.

对伴有临床证据的因低血压而导致低灌注和有明确证据的心脏充盈压增高（如颈静脉压力增高、PCWP增高）的患者，应该应用静脉用强心剂或血管加压素维持组织灌注和靶器官功能，以进一步决定最终治疗方案。

Standard treatment for septic shock includes antibiotics, intravenous fluids and vasopressor medicines (drugs to increase blood pressure)," explained the first study's lead author, Dr. Charles Sprung, director of the general intensive care unit, department of anesthesiology and critical care medicine at Hadassah Hebrew University Medical Center in Israel."Until our study, doctors in hospitals around the world were also routinely using steroids as adjunct therapy to help hundreds of thousands of patients in septic shock fight for their lives. Our study demonstrates that this adjunct therapy of hydrocortisone is not helpful for most patients with septic shock and, in fact, may be harmful.

标准的败血症性休克治疗包括抗生素、静脉补液和血管升压药物，"第一作者，以色列Hadassah Hebrew 大学医学中心麻醉学部与危重症医学部综合加强监护单元主任Charles Sprung博士解释道，"在我们的研究之前，全世界的医生常规使用类固醇激素辅助治疗成千上万的败血症性休克患者，但是我们的研究证实了氢化可的松对多数患者并没有辅助治疗的作用，实际上可能是有害的。

Hydrocortisone is widely used in patients with septic shock even though a survival benefit has been reported only in patients who remained hypotensive after fluid and vasopressor resuscitation and whose plasma cortisol levels did not rise appropriately after the administration of corticotropin.

1月10日《新英格兰医学杂志》报道，Hadassah希伯来大学医学中心等地的研究人员证实，无论是对所有的脓毒性休克患者还是只针对那些对促肾上腺皮质激素无反应的患者，氢化可的松都不能改善生存率或逆转休克症状；但是，对于已经逆转了休克进程的患者来说，氢化可的松可以加快休克的恢复。

BioActive Glycopeptides and Peptidoglycans promote bradykinin action and activate glomerulus and nephrocyte to make vasopressor factor (angiotension-I)-suppressing as ACE-blocking to anti-hypertension and against Chronic fatigue syndrome, Nephrosis, glomerulonephritis, congestive heart failure.

天然生物活性醣胜肽与肽聚醣，可作为医师处方调配最好的医用营养素补充剂：提升血管舒缓激肽的活动、促进活化肾小球与肾原细胞，抑制血管增压因子、高血压、对抗慢性疲劳综合症、肾变病、血管球性肾炎、充血性心脏衰竭。

BioActive Glycopeptides and Peptidoglycans promote bradykinin action and activate glomerulus and nephrocyte to make vasopressor factor (angiotension-I)-suppressing as ACE-blocking to anti-hypertension and against Chronic fatigue syndrome, Nephrosis, glomerulonephritis, congestive heart failure.

天然生物活性醣胜肽与肽聚醣，可作为医师处方调配最好的医用营养素补充剂：提升血管舒缓激肽的活动、促进活化肾小球与肾原细胞，抑制血管增压因数、高血压、对抗慢性疲劳综合症、肾变病、血管球性肾炎、充血性心脏衰竭。

In the United States, chronic alcoholism and hepatitis C are the most common ones.

在美国，慢性酒精中毒，肝炎是最常见的。

If you have any questions, you can contact me anytime.

如果有任何问题，你可以随时联系我。